Methylprednisolone therapy in laser injury of the retina

Graefes Arch Clin Exp Ophthalmol. 1993 Dec;231(12):729-36. doi: 10.1007/BF00919289.

Abstract

The efficacy of methylprednisolone in argon-laser-induced retinal injury in primates was evaluated by clinical, histopathologic, and morphometric criteria. Methylprednisolone was given with a loading dose of 30 mg/kg followed by 5.4 mg/kg per hour in three different regimens: (1) starting 24 h before laser and continuing for 4 days; (2) starting immediately after laser and continuing for 4 days; and (3) starting immediately after laser and continuing for 8 h. Fundus photography, fluorescein angiography, and histologic examination showed significant beneficial effects of all three treatments compared to controls. Morphometrically, at the center of the lesion, the width of disrupted outer nuclear layer, the width of the affected RPE, and the percentage of residual photoreceptor nuclei confirmed the efficacies of treatment regimens 1 and 2, but not treatment regimen 3.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Fluorescein Angiography
  • Fundus Oculi
  • Lasers / adverse effects*
  • Macaca fascicularis
  • Methylprednisolone / therapeutic use*
  • Photoreceptor Cells / drug effects
  • Photoreceptor Cells / pathology
  • Photoreceptor Cells / radiation effects
  • Pigment Epithelium of Eye / drug effects
  • Pigment Epithelium of Eye / pathology
  • Pigment Epithelium of Eye / radiation effects
  • Radiation Injuries, Experimental / drug therapy*
  • Radiation Injuries, Experimental / etiology
  • Radiation Injuries, Experimental / pathology
  • Retina / drug effects
  • Retina / pathology
  • Retina / radiation effects*

Substances

  • Methylprednisolone